InvestorsHub Logo
icon url

crescentmotor

03/20/24 6:53 PM

#454585 RE: Pazzo1212 #454583

We deserve an update on their Rett strategy.



Yes--and almost fifteen months after TLD was released from the 2b/III trial, not a word from AVXL on a possible regulatory path with the FDA. Why would peer review be necessary to begin discussions with the FDA?
icon url

poguemahone

03/20/24 7:05 PM

#454586 RE: Pazzo1212 #454583

Not only do shareholders deserve to know what the plan is, but the Rett families deserve to know it as well.

This is why our CEO falls so short on so many fronts.
icon url

ignatiusrielly35

03/20/24 8:30 PM

#454597 RE: Pazzo1212 #454583

Rett is immaterial at this point.